Coronavirus R&D Gateway

While providing a good framework, more work is needed to address five priorities for ensuring the successful lifting of lockdown measures.

After ‘thoughtful’ initial response, science funders worry about longer term impact of mobility restrictions on international cooperation

Ursula von der Leyen promises reworked budget will provide forceful response to crisis, as she confirms fundraising event for vaccine research on May 4

Brussels provides route map for countries as they can begin lifting sweeping restrictions

Solar-powered hand disinfection station beats 500 other ideas to win Global Hack event

The life science industry is all hands on deck in the race to develop vaccines, therapies and diagnostics in the fight against coronavirus. But while some prosper, many in the sector are forced to halt clinical trials and mothball labs

Action plan includes clinical trials funding and new research task force to share COVID-19 knowledge

The EU has mobilised fairly quickly, with a good mix of funding for research on the coronavirus pandemic, says Matthias Kleiner, president of the Leibniz Association